Vericel Corp. (VCEL)

[commoncentsinvestor]

The best way to become disappointed is to have unrealistic expectations. No, revenues this quarter are NOT going to be $25M. No, there will be NO profit this quarter.

According to the CEO, time lapse between biopsies and implantations is 4 to 6 months. So it is just not possible for this to be a HUGE revenue quarter. Personally I will be happy with $14M in revenues and loss of .10 or less.

If they hit those numbers and the share price goes down, I will be happy to make a big addition to my already boatload of VCEL shares.

What I am 99% sure of is that in 2018 Vericel is going to do at least $100M in revenues. The average price to sales ratio for biotechs is 5.82. So if VCEL is given just an average markup, it would be a market cap of $582M. That would be a share price of $18.18 which is almost a 5 bagger from todays price.

GOOD THINGS COME TO THOSE WHO WAIT.